Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00867152 · ClinicalTrials.gov registry record · Phase 1
GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir
A Phase 1 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 1
- Development phase
- 17
- Enrollment target
NCT00867152 is a Phase 1 study that has completed, run by ViiV Healthcare. The registered enrollment target is 17 participants.
The verdict
NCT00867152, a Phase 1 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 17 participants
- Enrollment target
Study Summary
A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects
Interventions
- DRUG Ritonavir
- DRUG Etravirine
- DRUG Darunavir
- DRUG GSK1349572
- DRUG Lopinavir/ritonavir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2009-04 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00867152
The ClinicalTrials.gov registry entry for NCT00867152 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ritonavir is the first listed.
NCT00867152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00867152 about?
NCT00867152 is a clinical study titled "GSK1349572 Drug Interaction With Etravirine and Either Darunavir/Ritonavir or Lopinavir/Ritonavir". A Phase I, open label, randomized, three period, one-way, two cohort, adaptive crossover study to evaluate the effect of darunavir/ritonavir plus etravirine and lopinavir/ritonavir plus etravirine on GSK1349572 pharmacokinetics in healthy adult subjects
What is the current status of trial NCT00867152?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 17 participants. The study started on 2009-04. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00867152?
The interventions under investigation include: Ritonavir (DRUG), Etravirine (DRUG), Darunavir (DRUG), GSK1349572 (DRUG), Lopinavir/ritonavir (DRUG).
Who is sponsoring clinical trial NCT00867152?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.